ACAD vs MSFT · P/E 15, rev $576.0M vs P/E 39, rev $331.84B
ACADIA Pharmaceuticals Inc (ACAD) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Not investment advice. Open the ACAD and MSFT stock pages for the full models.
Not investment advice.